Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic DrugNCT06641076MoonLake Immunotherapeutics AGPhase 3Active not recruiting2026-05-28Actual
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponseNCT06641089MoonLake Immunotherapeutics AGPhase 3Active not recruiting2027-01-04Estimated
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).NCT06641414Ascentage Pharma Group Inc.Phase 3Recruiting2029-06Estimated
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and EfficacyNCT06643260Can-Fite BioPharmaPhase 3Not yet recruiting2027-12Estimated
Suprachoroidal Administration in Subjects With Metastases to the ChoroidNCT06643884Aura BiosciencesPhase 2Recruiting2026-11-30Estimated
A Study to Assess TTI-0102 vs Placebo in MELAS PatientsNCT06644534Thiogenesis Therapeutics, Inc.Phase 2Completed2026-01-12Actual
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell TherapiesNCT06652633LKFTPhase 3Recruiting2039-07Estimated
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous MalformationsNCT06653842PVLAPhase 2Active not recruiting2025-11-21Actual
B-FREE Chronic Babesiosis StudyNCT0665635160 Degrees Pharmaceuticals LLCPhase 2Recruiting2027-02Estimated
ALTO-100 in Bipolar Disorder With Depression (BD-D)NCT06656416Alto NeurosciencePhase 2Recruiting2027-09Estimated
A Study to Evaluate the Safety and Efficacy of NDV-01 in Participants With NMIBCNCT06663137RLMDPhase 2Recruiting2027-11Estimated
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1NCT06667453PEPGPhase 2Recruiting2027-03Estimated
A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 InfectionNCT06672055VaxartPhase 2Active not recruiting2027-05Estimated
A Phase 3 Study of NTLA-2001 in ATTRv-PNNCT06672237Intellia TherapeuticsPhase 3Active not recruiting2027-07Estimated
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of AtaciceptNCT06674577VERAPhase 2Enrolling by invitation2031-05-21Estimated
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic CancerNCT06678659RXRXPhase 1, Phase 2Recruiting2029-07Estimated
Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AMLNCT06679582STROPhase 1, Phase 2Terminated2025-01-21Actual
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular CarcinomaNCT06679985CHRSPhase 2Active not recruiting2027-09Estimated
A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic TherapyNCT06680258Tempest TherapeuticsPhase 3Not yet recruiting2028-12Estimated
A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese PatientsNCT06682572VSTMPhase 2Active not recruiting2025-12Estimated
A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationNCT06682806Prelude Therapeutics IncorporatedPhase 2Terminated2026-01-23Actual
A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)NCT06685692ALDXPhase 2Completed2025-06-18Actual
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With HypogonadismNCT06689085Halozyme TherapeuticsPhase 3Recruiting2028-03Estimated
Controlled Study, Performed to Evaluate the Safety and Efficacy of EscharEx and Its Placebo (Gel Vehicle) Compared to Non-surgical Standard of Care in Participants With Venous Leg Ulcers (VLU)NCT06690177MDWDPhase 2Not yet recruiting2028-11-04Estimated
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsNCT06695845Jazz PharmaceuticalsPhase 2Recruiting2026-12-31Estimated
A Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated With the INTERCEPT Blood System for Platelets With LED Illuminator.NCT06697223Cerus CorporationPhase 2Completed2025-06-02Actual
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.NCT06697301Eikon TherapeuticsPhase 2, Phase 3Recruiting2035-12Estimated
CLOVER - CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched RegimenNCT06699836CytoDyn, Inc.Phase 2Active not recruiting2028-01Estimated
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 VariantNCT06701396Vanda PharmaceuticalsPhase 3Recruiting2025-06-30Estimated
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)NCT06708299CRDLPhase 3Recruiting2026-09-21Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.